Fri, Jul 11, 2014, 6:32 AM EDT - U.S. Markets open in 2 hrs 58 mins

Recent

% | $
Quotes you view appear here for quick access.

Puma Biotechnology, Inc. Message Board

  • busy26795 busy26795 May 23, 2013 9:38 AM Flag

    PBYI Puma Biotechnology price target raised to $59 from $40 at BofA/Merrill

    Puma Biotechnology price target raised to $59 from $40 at BofA/Merrill

    PBYI Puma Biotechnology price target raised to $59 from $40 at BofA/Merrill
    BofA/Merrill raised Puma Biotechnology estimates to reflect increased value for tyrosine kinase inhibitor neratinib following management's plans to initiate a "basket study" in order to evaluate neratinib across a large range of solid tumors in patients with activating mutations. The firm believes neratinib could be a $2B+ drug. Shares are Buy rated

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
PBYI
65.15-0.51(-0.78%)Jul 10 4:02 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.